- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 379206, 13 pages
Therapeutic Time Window for Edaravone Treatment of Traumatic Brain Injury in Mice
1Department of Anatomy, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
2Department of Emergency and Critical Care Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
Received 5 January 2013; Revised 8 March 2013; Accepted 11 March 2013
Academic Editor: Norma Possa Marroni
Copyright © 2013 Kazuyuki Miyamoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. W. Brown, E. P. Elovic, S. Kothari, S. R. Flanagan, and C. Kwasnica, “Congenital and acquired brain injury. 1. Epidemiology, pathophysiology, prognostication, innovative treatments, and prevention,” Archives of Physical Medicine and Rehabilitation, vol. 89, no. 3, pp. S3–S8, 2008.
- E. M. Manno, A. A. Rabinstein, E. F. M. Wijdicks et al., “A prospective trial of elective extubation in brain injured patients meeting extubation criteria for ventilatory support: A Feasibility Study,” Critical Care, vol. 12, no. 6, article R138, 2008.
- W. Rutland-Brown, J. A. Langlois, K. E. Thomas, and Y. L. Xi, “Incidence of traumatic brain injury in the United States, 2003,” Journal of Head Trauma Rehabilitation, vol. 21, no. 6, pp. 544–548, 2006.
- E. Zaloshnja, T. Miller, J. A. Langlois, and A. W. Selassie, “Prevalence of long-term disability from traumatic brain injury in the civilian population of the United Statet 2005,” Journal of Head Trauma Rehabilitation, vol. 23, no. 6, pp. 394–400, 2008.
- H. Yoshida, H. Yanai, Y. Namiki, K. Fukatsu-Sasaki, N. Furutani, and N. Tada, “Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury,” CNS Drug Reviews, vol. 12, no. 1, pp. 9–20, 2006.
- T. Watanabe, S. Yuki, M. Egawa, and H. Nishi, “Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions,” Journal of Pharmacology and Experimental Therapeutics, vol. 268, no. 3, pp. 1597–1604, 1994.
- Y. Inokuchi, S. Imai, Y. Nakajima et al., “Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 329, no. 2, pp. 687–698, 2009.
- G. H. Wang, Z. L. Jiang, Y. C. Li, et al., “Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats,” Journal of Neurotrauma, vol. 28, pp. 2123–2134, 2011.
- E. Otomo, H. Tohgi, K. Kogure et al., “Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters,” Cerebrovascular Diseases, vol. 15, no. 3, pp. 222–229, 2003.
- P. Sharma, M. Sinha, R. K. Shukla, R. Garg, R. Verma, and M. K. Singh, “A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke,” Annals of Indian Academy of Neurology, vol. 14, no. 2, pp. 103–106, 2011.
- R. Tabrizchi, “Edaravone Mitsubishi-Tokyo,” Current Opinion in Investigational Drugs, vol. 1, no. 3, pp. 347–354, 2000.
- S. Ohta, Y. Iwashita, H. Takada, S. Kuno, and T. Nakamura, “Neuroprotection and enhanced recovery with edaravone after acute spinal cord injury in rats,” Spine, vol. 30, no. 10, pp. 1154–1158, 2005.
- K. Dohi, K. Satoh, T. Nakamachi et al., “Does edaravone (MCI-186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury?” Antioxidants and Redox Signaling, vol. 9, no. 2, pp. 281–287, 2007.
- T. Itoh, T. Satou, S. Nishida et al., “Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats,” Neurochemical Research, vol. 35, no. 2, pp. 348–355, 2010.
- A. Munakata, H. Ohkuma, T. Nakano, N. Shimamura, K. Asano, and M. Naraoka, “Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 64, no. 3, pp. 423–428, 2009.
- K. Dohi, K. Satoh, Y. Mihara et al., “Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury,” Journal of Neurotrauma, vol. 23, no. 11, pp. 1591–1599, 2006.
- E. D. Hall, M. R. Detloff, K. Johnson, and N. C. Kupina, “Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury,” Journal of Neurotrauma, vol. 21, no. 1, pp. 9–20, 2004.
- A. Lewén, P. Matz, and P. H. Chan, “Free radical pathways in CNS injury,” Journal of Neurotrauma, vol. 17, no. 10, pp. 871–890, 2000.
- K. Dohi, H. Ohtaki, T. Nakamachi et al., “ (NOX2) in classically activated microglia exacerbates traumatic brain injury,” Journal of Neuroinflammation, vol. 7, no. 41, 2010.
- H. Mizushima, C. J. I. Zhou, K. Dohi et al., “Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1,” Journal of Comparative Neurology, vol. 448, no. 2, pp. 203–216, 2002.
- H. Ohtaki, A. Takaki, L. Yin et al., “Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice,” Acta Neurochirurgica, no. 86, pp. 191–194, 2003.
- D. L. Brody, C. Mac Donald, C. C. Kessens et al., “Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury,” Journal of Neurotrauma, vol. 24, no. 4, pp. 657–673, 2007.
- L. C. Schmued and K. J. Hopkins, “Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration,” Brain Research, vol. 874, no. 2, pp. 123–130, 2000.
- H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al., “Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638–14643, 2008.
- H. Inoue, H. Ohtaki, T. Nakamachi, S. Shioda, and Y. Okada, “Anion channel blockers attenuate delayed neuronal cell death induced by transient forebrain ischemia,” Journal of Neuroscience Research, vol. 85, no. 7, pp. 1427–1435, 2007.
- H. Ohtaki, T. Takeda, K. Dohi et al., “Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice,” Neuroscience Research, vol. 58, no. 4, pp. 349–355, 2007.
- S. Yamaguchi, M. H. Hussein, G. A. Daoud et al., “Edaravone, a hydroxyl radical Scavenger, ameliorates the severity of pulmonary hypertension in a porcine model of neonatal sepsis,” Tohoku Journal of Experimental Medicine, vol. 223, no. 4, pp. 235–241, 2011.
- T. Koizumi, H. Tanaka, S. Sakaki, and S. Shimazaki, “The therapeutic efficacy of edaravone in extensively burned rats,” Archives of Surgery, vol. 141, no. 10, pp. 992–995, 2006.
- Y. Sano, T. Motomura, F. Yamamoto, M. Fukuda, T. Mukai, and M. Maeda, “1-(3′-[125I]iodophenyl)-3-methy-2-pyrazolin-5-one: preparation, solution stability, and biodistribution in normal mice,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 8, pp. 1020–1025, 2010.
- A. Sonoda, N. Nitta, A. Seko et al., “Edaravone prevents bowel infarction after acute superior mesenteric artery thromboembolism using autologous fibrin clots in a rabbit model,” British Journal of Radiology, vol. 82, no. 981, pp. 711–715, 2009.
- E. Vandelle and M. Delledonne, “Peroxynitrite formation and function in plants,” Plant Science, vol. 181, pp. 534–539, 2011.
- M. D. Goodman, A. T. Makley, N. L. Huber et al., “Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury,” Journal of Surgical Research, vol. 165, no. 1, pp. 30–37, 2011.
- K. Miyamoto, H. Ohtaki, K. Dohi et al., “Edaravone increased regional cerebral blood flow after TBI,” Acta Neurochirurgica. In press.
- J. I. Oyama, S. Satoh, N. Suematsu et al., “Scavenging free radicals improves endothelial dysfunction in human coronary arteries in vivo,” Heart and Vessels, vol. 25, no. 5, pp. 379–385, 2010.
- K. Dohi, K. Satoh, T. Nakamachi et al., “Novel free radical monitoring in patients with neurological emergency diseases,” Acta Neurochirurgica, vol. 106, pp. 315–319, 2010.
- M. Bains and E. D. Hall, “Antioxidant therapies in traumatic brain and spinal cord injury,” Biochimica et Biophysica Acta, vol. 1822, pp. 675–684, 2012.
- W. Lo, T. Bravo, V. Jadhav, E. Titova, J. H. Zhang, and J. Tang, “NADPH oxidase inhibition improves neurological outcomes in surgically-induced brain injury,” Neuroscience Letters, vol. 414, no. 3, pp. 228–232, 2007.
- J. Dawson, K. R. Lees, C. J. Weir et al., “Baseline serum urate and 90-day functional outcomes following acute ischemic stroke,” Cerebrovascular Diseases, vol. 28, no. 2, pp. 202–203, 2009.
- C. W. P. M. Hukkelhoven, E. W. Steyerberg, E. Farace, J. D. F. Habbema, L. F. Marshall, and A. I. R. Maas, “Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials,” Journal of Neurosurgery, vol. 97, no. 3, pp. 549–557, 2002.
- T. Nakase, S. Yoshioka, and A. Suzuki, “Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke,” BMC Neurology, vol. 11, article 39, 2011.
- H. Utsumi, K. I. Yamada, K. Ichikawa et al., “Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 5, pp. 1463–1468, 2006.